A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity

Clinical trial NCT06862908 · RECRUITING

Trial details

NCT number: NCT06862908
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity Heart Failure With Preserved Ejection Fraction (HFPEF)Heart Failure With Mildly Reduced Ejection Fraction

Start date: 2025-04-01
Primary completion: 2026-09-24
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.